Montpellier

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Chronic rhinosinusitis with nasal polyps1 trial
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
• Lung cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Completed1 trial
• Enrolling by invitation1 trial
• Terminated1 trial

Lead sponsor

• Sanofi3 trials

Running trials

• Enrolling by invitation

  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  NCT06859099· Phase 3· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting

Closed trials

• Terminated

  Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA

  NCT05245071· Phase 2· Sanofi· Source

• Completed

  EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

  NCT04998604· Phase 4· Sanofi· Source